Intrauterine Insemination Predictor Factors

CompletedOBSERVATIONAL
Enrollment

2,970

Participants

Timeline

Start Date

January 1, 1997

Primary Completion Date

December 31, 2017

Study Completion Date

August 31, 2018

Conditions
Infertility
Interventions
PROCEDURE

Homologous intrauterine insemination (IUI)

"Patients were treated with HMG/rFSH according to classic protocols of therapy and monitoring. An injection of uHCG 5000 IU/ rHCG 250 mg was given to trigger ovulation. On the day of insemination, the semen sample was obtained through masturbation after a 2-5 day abstinence period and collected in a sterile cup. TMSC was determined by multiplying grade A or grade A + B sperm motility percentages by sperm volume and concentration. To evaluate sperm viability Eosin and Nigrosin (E\&N) staining was carried out according to WHO standards. Sperm capacitation was performed using density gradient centrifugation or swim-up procedure in order to remove seminal fluids and enhance sperm quality for IUI.~IUI was performed a t36 hours post-HCG. A fraction of the washed motile spermatozoa was inserted up to the uterine fundus and expelled into the uterine cavity. Daily treatment with micronized progesterone was prescribed for 14 days after IUI. Serum ß-HCG was determined 14 days after IUI."

Trial Locations (1)

20089

Paolo Emanuele Levi Setti, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT03836118 - Intrauterine Insemination Predictor Factors | Biotech Hunter | Biotech Hunter